title: Effects of modafinil on the sleep EEG depend on Val158Met genotype of COMT.
abstract: OBJECTIVE
  Modafinil may promote wakefulness by increasing cerebral dopaminergic neurotransmission, which importantly depends on activity of catechol-O-methyltransferase (COMT) in prefrontal cortex. The effects of modafinil on sleep homeostasis in humans are unknown. Employing a novel sleep-pharmacogenetic approach, we investigated the interaction of modafinil with sleep deprivation to study dopaminergic mechanisms of sleep homeostasis.
  
  
  METHODS
  Placebo-controlled, double-blind, randomized crossover study.
  
  
  METHODS
  Sleep laboratory in temporal isolation unit.
  
  
  METHODS
  22 healthy young men (23.4 +/- 0.5 years) prospectively enrolled based on genotype of the functional Val158Met polymorphism of COMT(10 Val/Val and 12 Met/Met homozygotes).
  
  
  METHODS
  2 x 100 mg modafinil and placebo administered at 11 and 23 hours during 40 hours prolonged wakefulness.
  
  
  RESULTS
  Subjective sleepiness and EEG markers of sleep homeostasis in wakefulness and sleep were equally affected by sleep deprivation in Val/Val and Met/Met allele carriers (placebo condition). Modafinil attenuated the evolution of sleepiness and EEG 5-8 Hz activity during sleep deprivation in both genotypes. In contrast to caffeine, modafinil did not reduce EEG slow wave activity (0.75-4.5 Hz) in recovery sleep, yet specifically increased 3.0-6.75 Hz and > 16.75 Hz activity in NREM sleep in the Val/Val genotype of COMT.
  
  
  CONCLUSIONS
  The Val158Met polymorphism of COMT modulates the effects of modafinil on the NREM sleep EEG in recovery sleep after prolonged wakefulness. The sleep EEG changes induced by modafinil markedly differ from those of caffeine, showing that pharmacological interference with dopaminergic and adenosinergic neurotransmission during sleep deprivation differently affects sleep homeostasis.
authors.affiliation: Institute of Pharmacology and Toxicology, University of Zürich, Zürich, Switzerland.
authors.forename: Sereina
authors.initials: S
authors.lastname: Bodenmann
authors.forename: Hans-Peter
authors.initials: HP
authors.lastname: Landolt
mesh_terms: D000483:Alleles; D001559:Benzhydryl Compounds / Q000494:pharmacology*; D002394:Catechol O-Methyltransferase / Q000235:genetics*; D000697:Central Nervous System Stimulants / Q000494:pharmacology*; D018592:Cross-Over Studies; D004311:Double-Blind Method; D004569:Electroencephalography / Q000187:drug effects*; D005583:Fourier Analysis; D006580:Genetic Carrier Screening; D005838:Genotype; D006706:Homeostasis / Q000187:drug effects / Q000235:genetics; D006801:Humans; D008297:Male; D000077408:Modafinil; D011110:Polymorphism, Genetic / Q000235:genetics*; D017397:Prefrontal Cortex / Q000187:drug effects; D011446:Prospective Studies; D012815:Signal Processing, Computer-Assisted; D012892:Sleep Deprivation / Q000235:genetics*; D012894:Sleep Stages / Q000187:drug effects / Q000235:genetics; D014851:Wakefulness / Q000187:drug effects / Q000235:genetics; D055815:Young Adult
chemical_list: D001559:Benzhydryl Compounds; D000697:Central Nervous System Stimulants; D002394:Catechol O-Methyltransferase; D000077408:Modafinil
references.citation: J Neurosci. 2008 Aug 20;28(34):8462-9
references.pmid: 18716204
references.citation: Ann N Y Acad Sci. 2008;1129:305-22
references.pmid: 18591490
references.citation: Neuropsychopharmacology. 2004 Oct;29(10):1933-9
references.pmid: 15257305
references.citation: J Sleep Res. 2008 Mar;17(1):11-5
references.pmid: 18275550
references.citation: Aviat Space Environ Med. 2004 Mar;75(3 Suppl):A147-54
references.pmid: 15018277
references.citation: Eur J Pharmacol. 1996 Apr 11;300(3):163-71
references.pmid: 8739204
references.citation: Pharmacogenetics. 1996 Jun;6(3):243-50
references.pmid: 8807664
references.citation: Psychopharmacology (Berl). 2003 Mar;166(2):127-38
references.pmid: 12552359
references.citation: Neuropsychopharmacology. 2008 Jun;33(7):1477-502
references.pmid: 17712350
references.citation: Am J Hum Genet. 2004 Nov;75(5):807-21
references.pmid: 15457404
references.citation: J Neurosci. 2006 Oct 11;26(41):10472-9
references.pmid: 17035531
references.citation: Clin Pharmacol Ther. 2009 Mar;85(3):296-304
references.pmid: 19037200
references.citation: Sleep. 1995 Dec;18(10):890-4
references.pmid: 8746397
references.citation: J Sleep Res. 2005 Sep;14(3):255-66
references.pmid: 16120100
references.citation: Hum Neurobiol. 1982;1(3):195-204
references.pmid: 7185792
references.citation: J Sleep Res. 1995 Dec;4(4):229-241
references.pmid: 10607162
references.citation: Electroencephalogr Clin Neurophysiol. 1981 May;51(5):483-95
references.pmid: 6165548
references.citation: Neuroimage. 2009 May 1;45(4):1232-40
references.pmid: 19349237
references.citation: Brain Res. 1995 Mar 27;675(1-2):67-74
references.pmid: 7796154
references.citation: Neuropharmacology. 2002 Jul;43(1):110-8
references.pmid: 12213265
references.citation: J Sleep Res. 2000 Mar;9(1):89-96
references.pmid: 10733694
references.citation: Neurosci Lett. 1995 Apr 7;189(1):43-6
references.pmid: 7603622
references.citation: J Sleep Res. 2008 Mar;17(1):34-41
references.pmid: 18275553
references.citation: Neuropsychopharmacology. 1995 May;12(3):229-38
references.pmid: 7612156
references.citation: Sleep Med. 2002 Jan;3(1):49-54
references.pmid: 14592254
references.citation: Lancet. 2007 Feb 10;369(9560):499-511
references.pmid: 17292770
references.citation: J Neurosci. 2001 Mar 1;21(5):1787-94
references.pmid: 11222668
references.citation: Clin Pharmacol Ther. 2007 May;81(5):692-8
references.pmid: 17329997
references.citation: Science. 2009 Apr 24;324(5926):516-9
references.pmid: 19390047
references.citation: Neuropsychopharmacology. 2009 Jun;34(7):1625-40
references.pmid: 19194377
references.citation: Chronobiol Int. 2008 Apr;25(2):297-308
references.pmid: 18533328
references.citation: Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15676-81
references.pmid: 16221767
references.citation: Mol Psychiatry. 2008 Aug;13(8):821-7
references.pmid: 18317466
references.citation: Neuroscience. 2000;101(3):523-9
references.pmid: 11113301
references.citation: Semin Neurol. 2009 Sep;29(4):320-39
references.pmid: 19742409
references.citation: J Pharmacol Exp Ther. 1997 Nov;283(2):757-69
references.pmid: 9353396
references.citation: Biochem Pharmacol. 2007 Apr 15;73(8):1157-71
references.pmid: 17288995
references.citation: J Sleep Res. 2006 Jun;15(2):133-41
references.pmid: 16704567
references.citation: Am J Physiol. 1996 Jan;270(1 Pt 2):R41-53
references.pmid: 8769783
references.citation: Curr Pharm Des. 2006;12(20):2457-71
references.pmid: 16842170
references.citation: Biochem Pharmacol. 2008 Jun 1;75(11):2070-9
references.pmid: 18384754
references.citation: Brain Res. 1993 Oct 29;626(1-2):190-9
references.pmid: 8281430
references.citation: Sleep. 2004 Sep 15;27(6):1181-94
references.pmid: 15532213
references.citation: JAMA. 2009 Mar 18;301(11):1148-54
references.pmid: 19293415
references.citation: Int J Clin Pharmacol Res. 1989;9(3):183-95
references.pmid: 2568348
references.citation: Sleep. 2005 Sep;28(9):1163-87
references.pmid: 16268386
references.citation: J Neurosci. 2009 Sep 2;29(35):10855-62
references.pmid: 19726643
references.citation: Neuroimage. 2009 Mar 1;45(1):44-51
references.pmid: 19071221
references.citation: J Neurosci. 2008 Aug 20;28(34):8454-61
references.pmid: 18716203